pharmaceutical-investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
medical-device-investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical-investing Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554
